DUSSELDORF, Germany, February 9/PRNewswire-FirstCall/ --Chief Executive Officer Dr. Axel Herberg (51) is not seeking reappointment and will leave the Management Board when his contract expires in June. The Supervisory Board has received this decision with regret and in its meeting today appointed as Herberg's successor from June the Management Board member of many years' standing, Uwe Rohrhoff (47). [more]
Oak Park, IL (January 5, 2010) – Siren Interactive, a relationship marketing agency focused on understanding the behaviors of patients and physicians dealing with chronic rare diseases, announces new hires. To support the influx of new business, in 2009 the company expanded in practically every department. A total of six new hires were added to the Siren team in Account Management, Project Management, Planning and Creative. [more]
Oak Park, IL (January 26, 2010) – Siren Interactive Founder and President, Wendy White, is among the 18 women recently elected to the Board of Directors of the Healthcare Businesswomen’s Association (HBA). Members of the board are representative of the HBA’s diverse membership, which represents all aspects of the healthcare industry, from pharmaceutical and medical device companies to patient advocacy groups, healthcare communications and consulting firms across the US and Europe. [more]
TALLAHASSEE, Fla., Feb. 9 /PRNewswire/ -- LearnSomething Inc., a leader in eLearning products and services for food, drug and mass retailers, today announced that Phil Keough, President of Keoco, LLC, a leading pharmacy management consulting company, has joined LearnSomething's senior management as Chief Business Development Officer. [more]
MONROVIA, Calif.--(BUSINESS WIRE)--Feb 9, 2010 - Xencor, Inc., a company using Fc engineering for the discovery and development of next-generation antibodies, announced today the appointment of Edgardo Baracchini, Ph.D., to chief business officer. [more]
LINCOLNSHIRE, Ill.--(BUSINESS WIRE)--Feb 9, 2010 - BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) today announced the appointment of Jeffrey W. Winkelman, Ph.D., J.D. as vice president, oncology programs. His primary responsibilities will be management of BioSante's oncology products including collaborations with John Hopkins Sidney Kimmel Cancer Center, contracts, licensing and intellectual property. [more]
Montvale, NJ, Feb. 9, 2010 – The PDR Network, already the largest distributor of FDA-approved drug information, Alerts and REMS programs to physicians, has added two top regulatory and risk executives to its management team and expanded its REMS and pharmaceutical risk offerings. [more]
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Feb 8, 2010 - Biogen Idec , a global biotechnology leader in the discovery, development, manufacturing and commercialization of innovative therapies, today announced that John R. Richert, M.D., will be joining the Company as a Senior Fellow in Neurology Research and Development and Nancy D. Richert, M.D., Ph.D., will be joining as a Fellow in Neurology Research and Development. [more]
KING OF PRUSSIA, Pa.--(BUSINESS WIRE)--Feb 8, 2010 - Trevena Inc., a leader in the discovery of G-protein coupled receptor (GPCR) biased ligands, announced today that it has named David Soergel, M.D. vice president and head, clinical development. In this role, Dr. Soergel is responsible for shaping Trevena's clinical strategy and the operational execution of its development programs. [more]
MADISON, Wis.--(BUSINESS WIRE)--Feb 8, 2010 - BioForward, the member-driven organization that represents the state's biotechnology industry, today announced the 2010 executive committee members of its board of directors. The BioForward Executive Committee Board Members are: [more]
MADISON, Wis.--(BUSINESS WIRE)--Feb 8, 2010 - BioForward, the member-driven organization that represents the state's biotechnology industry, today announced the 2010 executive committee members of its board of directors. The BioForward Executive Committee Board Members are: [more]
SALT LAKE CITY--(BUSINESS WIRE)--Feb 8, 2010 - The Utah Technology Council (UTC) (www.utahtechcouncil.org) recently announced new members to its Board of Trustees. [more]
LAWRENCEVILLE, N.J., Feb. 8 /PRNewswire/ -- Aton Pharma, Inc., a diversified specialty pharmaceutical company, announced today that Michael H. Richardson has joined the company as Vice President, Commercial Operations for the newly formed Orphan Drug Business Unit. Donald A. Fishbein assumes the same role for the Ophthalmic Business Unit. A wholly owned subsidiary of Princeton Pharma Holdings LLC, Aton is focused on the development and commercialization of unique products in ophthalmology and orphan diseases. [more]
RENO, Nev., Feb. 8 /PRNewswire/ -- The Whittemore Peterson Institute for Neuro-Immune Disease (WPI) has recently announced Dr. Donnica Moore, a distinguished women's health expert, as its new celebrity spokesperson and advocate. Dr. Moore will join WPI in its efforts to help raise awareness and funding for its research of XMRV and associated neuro-immune diseases, including Chronic Fatigue Syndrome. [more]
NEW YORK, Feb. 8 /PRNewswire/ -- MBS Value Partners, a strategic communications firm specializing in investor relations and corporate communications for domestic and international clients, announced today that Lisa Lettieri and Matthew Haines have joined as Managing Directors.
[more]
SAN DIEGO, Feb. 8 /PRNewswire-FirstCall/ -- Neurocrine Biosciences, Inc. (NASDAQ:NBIX) announced today that it has appointed William H. Rastetter Ph.D. to its Board of Directors effective immediately. He is the current Chairman and Chief Executive Officer of Receptos, Inc., and former Executive Chairman of Biogen Idec, Inc. [more]
LOS ALTOS, Calif., Feb. 8 /PRNewswire/ -- InteKrin Therapeutics Inc announced today that the Company's co-founder and Scientific Advisory Board Chairman, Christos Mantzoros, M.D., DSc., FACP, FACE, has been appointed Professor of Medicine at Harvard Medical School and Professor in Environmental Health at the Harvard School of Public Health. [more]
HELSINKI, February 8/PRNewswire/ -- As of January 2010 Mr. Steffen Mittwich has been appointed as new CEO for Atacama Labs Oy, a Finnish specialty pharmaceutical company, which has developed a unique pneumatic dry granulation method called PDG Technology(TM). Mr. Mittwich is based in Geneva, Switzerland. [more]
Martinsried/Munich, Germany, February 8, 2010 -- SuppreMol GmbH, a privately held biopharmaceutical company developing novel therapeutics for the treatment of autoimmune diseases, today announced that Dr. Robert Phelps has joined the Company as Head of Business Development & Licensing. [more]
Mergers & Acquisitions, Partnerships, & Collaborations 2010 – Review and Outlook
This PharmaLive Special Report analyzes the healthcare industry’s M&As of 2009, providing a comprehensive listing of companies’ M&A activity and detailing the top 20 deals within each of the Pharmaceutical, Biotechnology, Specialty, and Medical Device sectors, and previews potential M&A activity within the healthcare arena for 2010.
The introductory rate of $395 expires February 17, 2010.
